Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06768138Phase 3Recruiting
A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by CHRU de Nancy - Hôpital Central. Started Jun 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06768138.